Conservative Management Following Complete Clinical Response to Neoadjuvant Chemotherapy of Muscle Invasive Bladder Cancer: Contemporary Outcomes of a Multi-Institutional Cohort Study-Reference-Cited by-同舟云学术

Conservative Management Following Complete Clinical Response to Neoadjuvant Chemotherapy of Muscle Invasive Bladder Cancer: Contemporary Outcomes of a Multi-Institutional Cohort Study

Published:2018-11 Issue:5 Volume:200 Page:1005-1013
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Mazza Patrick¹,Moran George W.¹,Li Gen¹²,Robins Dennis J.¹,Matulay Justin T.¹,Herr Harry W.³,Decastro Guarionex J.¹,McKiernan James M.¹,Anderson Christopher B.¹

Affiliation:

1. Department of Urology, Herbert Irving Cancer Center, Columbia University Medical Center, New York, New York

2. Department of Biostatistics, Mailman School of Public Health, Columbia University, New York, New York

3. Memorial Sloan Kettering Cancer Center, New York, New York

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference27 articles.

1. Cancer statistics, 2018;Siegel;CA Cancer J Clin,2018

2. Epidemiology and risk factors of urothelial bladder cancer;Burger;Eur Urol,2013

3. Treatment of non-metastatic muscle-invasive bladder cancer: AUA/ASCO/ASTRO/SUO guideline;Chang;J Urol,2017